Barcelona, Spain

Raul Andero Gali

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Emory University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raul Andero Gali. Retrieved from https://idiyas.com/inventor/raul-andero-gali

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Raul Andero Gali

Introduction

Raul Andero Gali is an accomplished inventor based in Barcelona, Spain. He has made significant contributions to the field of neuroscience, particularly in the management of conditioned fear. His work focuses on innovative methods that utilize neurokinin receptor antagonists to address conditions such as Post-Traumatic Stress Disorder (PTSD).

Latest Patents

Gali holds a patent titled "Methods of managing conditioned fear with neurokinin receptor antagonists." This patent relates to managing conditioned fear and conditions induced by experiencing or witnessing an extreme traumatic event. The methods involve administering an effective amount of a neurokinin 3 receptor antagonist to a subject in need. In certain embodiments, the subject is diagnosed with PTSD. The specific neurokinin 3 receptor antagonist mentioned in the patent is (R)—N-{{3-[1-Benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]prop-1-yl}-4-phenylpiperidin-4-yl}-N-methylacetamine or its salts.

Career Highlights

Gali is affiliated with Emory University, where he continues to advance his research in neuroscience. His work has garnered attention for its potential to improve treatment options for individuals suffering from trauma-related conditions.

Collaborations

One of Gali's notable collaborators is Kerry J Ressler, who shares a commitment to exploring innovative solutions in the field of mental health.

Conclusion

Raul Andero Gali's contributions to the management of conditioned fear through neurokinin receptor antagonists represent a significant advancement in neuroscience. His work has the potential to impact the treatment of PTSD and improve the lives of many individuals affected by trauma.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…